These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 24445078

  • 1. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ.
    Periasamy S, Hsu DZ, Chang PC, Liu MY.
    J Nutr Biochem; 2014 Mar; 25(3):337-44. PubMed ID: 24445078
    [Abstract] [Full Text] [Related]

  • 2. Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis.
    Periasamy S, Chien SP, Chang PC, Hsu DZ, Liu MY.
    J Nutr Biochem; 2014 Feb; 25(2):232-40. PubMed ID: 24445049
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic sesame oil attenuates sinusoidal obstruction syndrome by inhibiting matrix metalloproteinase-9 and oxidative stress.
    Periasamy S, Yang SS, Chen SY, Chang CC, Liu MY.
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):529-37. PubMed ID: 22821006
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J.
    Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
    [Abstract] [Full Text] [Related]

  • 5. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Mar; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 6. [Peroxisome proliferator activated receptor gamma activation and overexpression prevent hepatocellular apoptosis of nutritional fibrotic steatohepatitis in mice].
    Nan YM, Han F, Kong LB, Li Y, Wang RQ, Zhao SX.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):521-6. PubMed ID: 22152244
    [Abstract] [Full Text] [Related]

  • 7. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, Poon TC, Sung JJ.
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC.
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [Abstract] [Full Text] [Related]

  • 11. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.
    Wang RQ, Nan YM, Wu WJ, Kong LB, Han F, Zhao SX, Kong L, Yu J.
    Lipids Health Dis; 2011 Feb 12; 10():31. PubMed ID: 21314960
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G.
    Hepatology; 2009 Mar 12; 49(3):989-97. PubMed ID: 19115316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 12; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K.
    Biochem Biophys Res Commun; 2004 Feb 27; 315(1):187-95. PubMed ID: 15013444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PPARgamma is essential for protection against nonalcoholic steatohepatitis.
    Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, Sung JJ, Yu J.
    Gene Ther; 2010 Jun 27; 17(6):790-8. PubMed ID: 20376096
    [Abstract] [Full Text] [Related]

  • 20. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.
    Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.